Cytotoxicity of trichothecenes to human solid tumor cells in vitro

被引:21
作者
Choi, SU [1 ]
Choi, EJ [1 ]
Kim, KH [1 ]
Kim, NY [1 ]
Kwon, BM [1 ]
Kim, SU [1 ]
Bok, SH [1 ]
Lee, SY [1 ]
Lee, CO [1 ]
机构
[1] KIST,KOREA RES INST BIOSCI & TECHNOL,BIOPROD RES GRP,TAEJON 305606,SOUTH KOREA
关键词
trichothecenes; Gliocladium; Trichothecium; cytotoxicity; human tumor cell line;
D O I
10.1007/BF02976812
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The trichothecenes are sesquiterpenoid mycotoxins characterized by the 12,13-epoxytrichothec-9-ene ring system. We have tested cytotoxicity of several naturally-occurring or synthesized trichothecenes against human solid tumor cell lines. Among them, trichothecin (I) and 4-beta-Acetoxy-12,13-epoxytrichothec-9-ene (trichodermin, II) exhibited highly cytotoxic activities. 4-beta-Hydroxy-12,13-epoxytrichothec-9-ene (trichodermol, III) and 4-beta-Methoxy-12,13-epoxytrichothec-9-ene (IV) had mild cytotoxicities. But 12,13-Epoxytrichothec-9-ene-4-one (V) and 4-alpha-Hydroxy-12,13-epoxytrichothec-9-ene(VI) had no cytotoxicities up to 10 mu g/ml. And in the tested cell lines, HCT15 colon cancer cell line was the most sensitive to all tested trichothecenes.
引用
收藏
页码:6 / 11
页数:6
相关论文
共 28 条
[1]  
ADLER SS, 1984, CANCER TREAT REP, V68, P423
[2]   STRUCTURE ACTIVITY STUDIES OF TRICHOTHECENES - CYTO-TOXICITY OF ANALOGS AND REACTION-PRODUCTS DERIVED FROM T-2 TOXIN AND NEOSOLANIOL [J].
ANDERSON, DW ;
BLACK, RM ;
LEE, CG ;
POTTAGE, C ;
RICKARD, RL ;
SANDFORD, MS ;
WEBBER, TD ;
WILLIAMS, NE .
JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (03) :555-562
[3]  
Bamburg J.R., 1983, PROGR MOL SUBCELLULA, P41
[4]   STRUCTURE-FUNCTION STUDIES OF T-2-MYCOTOXIN WITH A MONOCLONAL-ANTIBODY [J].
CHANH, TC ;
HEWETSON, JF .
IMMUNOPHARMACOLOGY, 1991, 21 (02) :83-89
[5]  
Cole R.J., 1981, HDB TOXIC FUNGAL MET
[6]   PHASE-II EVALUATION OF ANGUIDINE (NSC-141537) IN 5-DAY COURSES IN COLORECTAL ADENOCARCINOMA - A SOUTHEASTERN CANCER STUDY-GROUP TRIAL [J].
DESIMONE, PA ;
GRECO, FA ;
LESSNER, HF ;
BARTOLUCCI, A .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1986, 9 (03) :187-188
[7]  
FORSELL JH, 1985, APPL ENVIRON MICROB, V43, P1523
[8]  
GOETSCH L, 1990, ANTICANCER RES, V10, P1013
[9]  
JOHN WK, 1979, METHODS CANC RES, V16, P127
[10]  
KANETO T, 1982, J MED CHEM, V27, P579